Literature DB >> 24013541

Mammary artery to saphenous vein composite T grafts for coronary artery bypass: late follow-up.

Y Mayorchak1, Hs Paterson, J B Ryan, K Byth, L M Robinson, P Kovoor, A R Denniss.   

Abstract

AIM: Composite arterial grafts using a T configuration from the left internal mammary artery (LIMA) are commonly used for coronary artery surgery. Little data exist regarding the use of saphenous vein (SV) in composite grafts from the LIMA. This study aimed to determine whether LIMA patency was reduced by the attachment of a SV T graft.
METHODS: Patients (N.=166) who underwent coronary bypass surgery using the LIMA for SV graft inflow were identified from a database. Post discharge angiography was performed for investigation of symptoms or evidence of myocardial ischemia. Follow-up identified episodes of angiography, re-intervention and death.
RESULTS: Complete follow-up was obtained in 165 patients, mean 6 years (0-16 years). The mean patient age was 70 years and 43 patients underwent concomitant procedures. In 25 patients who underwent post discharge angiography, the LIMA and T anastomoses were widely patent in 14 patients. The SV graft was occluded at the T anastomosis in 8 patients and the distal limb of the LIMA was occluded in 2 patients. In no patients were the vein and LIMA both occluded.
CONCLUSION: The use of the LIMA for SV graft inflow does not appear to compromise the LIMA graft even when SV graft occlusion occurs.

Entities:  

Mesh:

Year:  2013        PMID: 24013541

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  2 in total

1.  Full myocardial revascularization with bilateral internal mammary artery Y grafts.

Authors:  Hugh S Paterson; Rishendran Naidoo; Karen Byth; Cheng Chen; A Robert Denniss
Journal:  Ann Cardiothorac Surg       Date:  2013-07

2.  The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels.

Authors:  Suna Aydin; Tuncay Kuloglu; Suleyman Aydin; Meltem Yardim; Davut Azboy; Zeki Temizturk; Ali Kemal Kalkan; Mehmet Nesimi Eren
Journal:  Cardiovasc J Afr       Date:  2017-08-31       Impact factor: 1.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.